Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Adma Biologics
(NQ:
ADMA
)
13.16
+0.08 (+0.61%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,801,437
Open
13.27
Bid (Size)
13.12 (7)
Ask (Size)
13.20 (10)
Prev. Close
13.08
Today's Range
12.94 - 13.35
52wk Range
3.060 - 14.03
Shares Outstanding
196,357,149
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Vir Biotechnology Stock Reaches 80-Plus RS Rating Benchmark
July 26, 2024
On Friday, Vir Biotechnology stock had its Relative Strength (RS) Rating upgraded to 82, up from 64 a day earlier.
Via
Investor's Business Daily
Beam Therapeutics Stock Earns RS Rating Jump To 85
July 24, 2024
On Wednesday, Beam Therapeutics stock now clears the 80 or higher Relative Strength Rating threshold, with a jump from 65 to 85.
Via
Investor's Business Daily
Performance
YTD
+189.23%
+189.23%
1 Month
+21.40%
+21.40%
3 Month
+100.92%
+100.92%
6 Month
+158.55%
+158.55%
1 Year
+237.44%
+237.44%
More News
Read More
Jim Cramer Recommends Not Selling Vertiv, Says Buy This Social Media Stock 'Hand Over Fist'
July 23, 2024
Via
Benzinga
Leslie's Issues Preliminary Financial Results, Joins Beyond Meat, Domino's And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
July 18, 2024
Via
Benzinga
Biotech Arvinas Stock Earns 82 RS Rating
July 17, 2024
Via
Investor's Business Daily
How Is The Market Feeling About ADMA Biologics?
July 11, 2024
Via
Benzinga
Expert Ratings For ADMA Biologics
July 09, 2024
Via
Benzinga
Peeling Back The Layers: Exploring ADMA Biologics Through Analyst Insights
June 20, 2024
Via
Benzinga
Denali Therapeutics Stock Gets Technical Rating Upgrade
July 16, 2024
Via
Investor's Business Daily
3 Millionaire-Making Stock Picks With Astounding Growth Potential
July 13, 2024
Via
InvestorPlace
Bull Run Alert: 3 Stocks Set to Soar in the Coming Months
July 11, 2024
Via
InvestorPlace
UroGen Pharma Stock Earns 91 RS Rating
June 27, 2024
Via
Investor's Business Daily
Arcellx Stock Earns Relative Strength Rating Upgrade
June 21, 2024
Via
Investor's Business Daily
Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87
June 20, 2024
Via
Investor's Business Daily
ADMA Biologics Analysts Increase Their Forecasts After Upbeat Results
May 10, 2024
Via
Benzinga
Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans
June 14, 2024
Via
Investor's Business Daily
Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade
June 12, 2024
Via
Investor's Business Daily
Krystal Biotech Stock Sees RS Rating Jump To 91
June 11, 2024
Via
Investor's Business Daily
Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday
May 10, 2024
Via
Benzinga
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 10, 2024
Via
Benzinga
ADMA Stock Earnings: ADMA Biologics Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
May 09, 2024
Via
Benzinga
ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
May 09, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Chart Of The Day: ADMA Biologics - Hitting New Highs
May 06, 2024
Via
Talk Markets
ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024
May 02, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.